Literature DB >> 18773275

A case of keratoconus progression associated with the use of topical latanoprost.

Shiro Amano1, Yoshiyuki Nakai2, Akiko Ko2, Kenji Inoue2, Masato Wakakura2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18773275     DOI: 10.1007/s10384-008-0554-6

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


× No keyword cloud information.
  5 in total

1.  Effect of latanoprost on cultured porcine corneal stromal cells.

Authors:  Kwou-Yeung Wu; Hwei-Zu Wang; Show-Jen Hong
Journal:  Curr Eye Res       Date:  2005-10       Impact factor: 2.424

2.  Effects of antiglaucoma drugs on collagen gel contraction mediated by human corneal fibroblasts.

Authors:  Yang Liu; Ryoji Yanai; Ying Lu; Shinji Hirano; Takeshi Sagara; Teruo Nishida
Journal:  J Glaucoma       Date:  2006-06       Impact factor: 2.503

3.  Inflammatory molecules in the tears of patients with keratoconus.

Authors:  Isabel Lema; Juan A Durán
Journal:  Ophthalmology       Date:  2005-04       Impact factor: 12.079

4.  Prostaglandins increase matrix metalloproteinase release from human ciliary smooth muscle cells.

Authors:  R N Weinreb; K Kashiwagi; F Kashiwagi; S Tsukahara; J D Lindsey
Journal:  Invest Ophthalmol Vis Sci       Date:  1997-12       Impact factor: 4.799

5.  Latanoprost stimulates secretion of matrix metalloproteinases in tenon fibroblasts both in vitro and in vivo.

Authors:  Holger Mietz; Johannes M Esser; Gerhard Welsandt; Norbert Kociok; Arno Hueber; Antonia Joussen; Peter Esser; Günter K Krieglstein
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-12       Impact factor: 4.799

  5 in total
  6 in total

1.  Cytotoxicity of pilocarpine to human corneal stromal cells and its underlying cytotoxic mechanisms.

Authors:  Xiao-Long Yuan; Qian Wen; Meng-Yu Zhang; Ting-Jun Fan
Journal:  Int J Ophthalmol       Date:  2016-04-18       Impact factor: 1.779

2.  Response to the comment on "The biomechanical properties of the cornea of patients with glaucoma treated with anti-glaucoma topical medication".

Authors:  Karin R Pillunat; Cosima Hermann; Eberhard Spoerl; Lutz E Pillunat
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-01-11       Impact factor: 3.117

3.  Effect of topical prostaglandins on the biomechanics and shape of the cornea.

Authors:  Shiro Amano; Ryohei Nejima; Kenji Inoue; Kazunori Miyata
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-08-10       Impact factor: 3.117

4.  Sustained release of an anti-glaucoma drug: demonstration of efficacy of a liposomal formulation in the rabbit eye.

Authors:  Jayaganesh V Natarajan; Sujay Chattopadhyay; Marcus Ang; Anastasia Darwitan; Selin Foo; Ma Zhen; Magdalene Koo; Tina T Wong; Subbu S Venkatraman
Journal:  PLoS One       Date:  2011-09-09       Impact factor: 3.240

5.  Nanomedicine for glaucoma: liposomes provide sustained release of latanoprost in the eye.

Authors:  Jayaganesh V Natarajan; Marcus Ang; Anastasia Darwitan; Sujay Chattopadhyay; Tina T Wong; Subbu S Venkatraman
Journal:  Int J Nanomedicine       Date:  2012-01-05

6.  The effect of Timolol 0.5% on the correction of myopic regression after LASIK.

Authors:  Hong Qi; Caifeng Gao; Yaxin Li; Xue Feng; Miao Wang; Yu Zhang; Yueguo Chen
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.